Biotech Acquisition Co Quarterly Liabilities and Equity in USD from Q3 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Biotech Acquisition Co quarterly Liabilities and Equity history and growth rate from Q3 2020 to Q3 2022.
Biotech Acquisition Co Liabilities and Equity for the quarter ending September 30, 2022 was $231M, a 0.3% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$231M	+$700K	+0.3%	Sep 30, 2022	10-Q	2022-11-22
Q2 2022	$230M	-$862K	-0.37%	Jun 30, 2022	10-Q	2022-08-22
Q1 2022	$230M	-$1.15M	-0.5%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$230M	+$230M		Dec 31, 2021	10-Q	2022-11-22
Q3 2021	$231M	+$231M		Sep 30, 2021	10-Q	2021-11-17
Q2 2021	$231M			Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$232M			Mar 31, 2021	10-Q	2021-05-24
Q4 2020	$89.5K^*			Dec 31, 2020	10-K	2022-03-08
Q3 2020	$89.5K^*			Sep 30, 2020	10-Q	2021-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.